524516 On Other Exchanges
Symbol
Exchange
524516 is not on other exchanges.

bacil pharma ltd (524516) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BACIL PHARMA LTD (524516)

Related News

No related news articles were found.

bacil pharma ltd (524516) Related Businessweek News

No Related Businessweek News Found

bacil pharma ltd (524516) Details

Bacil Pharma Limited manufactures and sells pharmaceuticals, medicinal chemicals, and botanical products. The company was incorporated in 1987 and is based in Mumbai, India.

Founded in 1987

bacil pharma ltd (524516) Top Compensated Officers

Manager
Total Annual Compensation: 180.0K
Chief Financial Officer
Total Annual Compensation: 180.0K
Compensation as of Fiscal Year 2016.

bacil pharma ltd (524516) Key Developments

Bacil Pharma Ltd Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2016

Bacil Pharma Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2016. For the quarter, the company reported loss from operations before other income, interest and exceptional items of INR 0.201 million against INR 0.301 million a year ago. Profit from ordinary activities before tax was INR 0.079 million against loss of INR 0.155 million a year ago. Net profit for the period was INR 0.079 million against net loss of INR 0.155 million a year ago. Basic and diluted loss per share was INR 0.03 against INR 0.03 a year ago. For the six months, the company reported loss from operations before other income, interest and exceptional items of INR 0.758 million against INR 0.687 million a year ago. Loss from ordinary activities before tax was INR 0.373 million against INR 0.442 million a year ago. Net loss for the period was INR 0.373 million against INR 0.442 million a year ago. Basic and diluted loss per share was INR 0.10 against INR 0.08 a year ago.

Bacil Pharma Ltd to Report Q2, 2017 Results on Nov 15, 2016

Bacil Pharma Ltd announced that they will report Q2, 2017 results on Nov 15, 2016

Bacil Pharma Ltd, Board Meeting, Nov 14, 2016

Bacil Pharma Ltd, Board Meeting, Nov 14, 2016. Agenda: To consider and approve the unaudited financial results of the company for the quarter and half year ended 30th September, 2016 as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, performance review and any business proposal; and to consider any other matter with the permission of the chair.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

524516 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 524516.
View Industry Companies
 

Industry Analysis

524516

Industry Average

Valuation 524516 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 151.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BACIL PHARMA LTD, please visit www.bacilpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.